Related Experiment Video
Updated: Aug 15, 2026
12:43
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
Published on: February 21, 2011
[Speech disorders in Alajouanine syndrome]
G Niedzielska1, E Katska, E Kurkowska
1Klinika Otolaryngologii Dzieciecej Foniatrii i Audiologii AM w Lublinie.
Otolaryngologia Polska = the Polish Otolaryngology
|September 11, 1999
Summary
Alajouanine syndrome, a rare congenital condition, involves facial nerve palsy and clubfoot. Early rehabilitation significantly improves speech disorders associated with this syndrome.
Area of Science:
- Neurology
- Pediatrics
- Speech-Language Pathology
Background:
- Alajouanine syndrome is a rare congenital disorder characterized by specific neurological and orthopedic manifestations.
- It typically presents with bilateral, central facial nerve palsy and abducens nerve palsy, alongside clubfoot.
- Understanding the full spectrum of Alajouanine syndrome is crucial for timely diagnosis and intervention.
Observation:
- This study focuses on the speech disorders observed in individuals with Alajouanine syndrome.
- The authors detail the specific communication challenges faced by patients.
- Detailed clinical observations highlight the impact of neurological deficits on speech production.
Findings:
- Individuals with Alajouanine syndrome frequently exhibit significant speech disorders.
- Early and targeted rehabilitation demonstrates a positive and helpful influence on speech function.
- Intervention strategies can mitigate the impact of congenital neurological deficits on communication.
Implications:
- Early rehabilitation is a key component in managing Alajouanine syndrome.
- Speech-language pathology interventions can improve quality of life for affected individuals.
- Further research into the neurodevelopmental aspects of Alajouanine syndrome is warranted.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:25Introduction to Language of Pathophysiology l
Pathophysiology investigates how biological mechanisms—typically starting at the cellular level—disrupt normal bodily functions. It bridges anatomy and physiology to explain the progression of disease. With this foundation, it is important to understand the following key terms used to describe disease processes: Diagnosis:The process of identifying a disease using clinical evaluation, including signs (objective evidence like rashes), symptoms (subjective experiences like pain), laboratory test...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...